## **Core Concept**
Hand-foot syndrome, also known as palmar-plantar erythrodysesthesia, is a side effect associated with certain chemotherapeutic agents. It is characterized by redness, swelling, and sometimes peeling of the skin on the palms of the hands and soles of the feet. This condition is often related to the use of specific types of cancer drugs.

## **Why the Correct Answer is Right**
The correct answer, **Capecitabine**, is a chemotherapeutic agent known to cause hand-foot syndrome. Capecitabine is a prodrug that is converted to 5-fluorouracil (5-FU) in the body, which is a nucleoside analog used in cancer chemotherapy. Hand-foot syndrome is a well-documented side effect of capecitabine and other drugs that are similar in mechanism, such as doxorubicin and certain tyrosine kinase inhibitors. The exact mechanism behind hand-foot syndrome is not fully understood, but it is thought to be related to the high concentration of drug or its metabolites in the skin, leading to damage and the observed symptoms.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is blank and does not provide a specific drug to evaluate.
- **Option B:** This option is also blank and does not offer a drug for consideration.
- **Option D:** Similarly, this option is blank and lacks a specific chemotherapeutic agent.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that hand-foot syndrome is a significant side effect of certain chemotherapeutic agents, notably **capecitabine**, and can impact the quality of life for patients undergoing treatment. Awareness of this side effect can help in early recognition and management, which may include dose adjustment, application of topical creams, and use of cooling packs to alleviate symptoms.

## **Correct Answer:** . Capecitabine